Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis.
Watson S, LaVigne CA, Xu L, Surdez D, Cyrta J, Calderon D, Cannon MV, Kent MR, Silvius KM, Kucinski JP, Harrison EN, Murchison W, Rakheja D, Tirode F, Delattre O, Amatruda JF, Kendall GC. Watson S, et al. Among authors: cannon mv. Cell Rep. 2023 Jan 31;42(1):112013. doi: 10.1016/j.celrep.2023.112013. Epub 2023 Jan 18. Cell Rep. 2023. PMID: 36656711 Free PMC article.
Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma.
Ringwalt EM, Currier MA, Glaspell AM, Chen CY, Cannon MV, Cam M, Gross AC, Gust M, Wang PY, Boon L, Biederman LE, Schwarz E, Rajappa P, Lee DA, Mardis ER, Carson WE, Roberts RD, Cripe TP. Ringwalt EM, et al. Among authors: cannon mv. Mol Ther Oncol. 2024 Sep 26;32(4):200886. doi: 10.1016/j.omton.2024.200886. eCollection 2024 Dec 19. Mol Ther Oncol. 2024. PMID: 39492947 Free PMC article.
Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone Sarcoma.
Ringwalt EM, Currier MA, Glaspell AM, Chen CY, Cannon MV, Cam M, Gross AC, Gust M, Wang PY, Boon L, Biederman LE, Schwarz E, Rajappa P, Lee DA, Mardis ER, Carson WE, Roberts RD, Cripe TP. Ringwalt EM, et al. Among authors: cannon mv. bioRxiv [Preprint]. 2024 Mar 3:2024.03.02.582994. doi: 10.1101/2024.03.02.582994. bioRxiv. 2024. PMID: 38464161 Free PMC article. Preprint.
Aberrant activation of wound healing programs within the metastatic niche facilitates lung colonization by osteosarcoma cells.
Reinecke JB, Jimenez Garcia L, Gross AC, Cam M, Cannon MV, Gust MJ, Sheridan JP, Gryder BE, Dries R, Roberts RD. Reinecke JB, et al. Among authors: cannon mv. bioRxiv [Preprint]. 2024 Sep 13:2024.01.10.575008. doi: 10.1101/2024.01.10.575008. bioRxiv. 2024. Update in: Clin Cancer Res. 2025 Jan 17;31(2):414-429. doi: 10.1158/1078-0432.CCR-24-0049 PMID: 38260361 Free PMC article. Updated. Preprint.
Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization.
McAloney CA, Makkawi R, Budhathoki Y, Cannon MV, Franz EM, Gross AC, Cam M, Vetter TA, Duhen R, Davies AE, Roberts RD. McAloney CA, et al. Among authors: cannon mv. Cell Oncol (Dordr). 2024 Feb;47(1):259-282. doi: 10.1007/s13402-023-00867-w. Epub 2023 Sep 7. Cell Oncol (Dordr). 2024. PMID: 37676378 Free PMC article.
39 results